Myfortic for the Treatment of Non-infectious Intermediate Uveitis

Mise à jour : Il y a 4 ans
Référence : NCT01092533

Femme et Homme

  • | Pays :
  • Germany
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The objective of this clinical trial is to evaluate the efficacy, safety and tolerability of enteric-coated mycophenolate sodium (Myfortic®) in combination with low-dose corticosteroids (Decortin H®) compared to a monotherapy with low-dose corticosteroids (Decortin H®) in subjects with chronic intraocular inflammation (non-infectious intermediate uveitis).


Critère d'inclusion

  • Uveitis, Intermediate

Liens